Navigation Links
BioScrip Reports Second Quarter 2014 Financial Results
Date:8/6/2014

in the PBM Services segment. The decline in gross profit margin percentage was driven primarily by the decline in the higher-margin PBM Services segment.

During the second quarter of 2014, Infusion Services segment Adjusted EBITDA was $16.2 million, compared to $14.0 million in the prior year quarter. The 15.7% improvement in Adjusted EBITDA in the Infusion Services segment resulted primarily from organic revenue growth and the acquisition of CarePoint Partners. Infusion Services segment Adjusted EBITDA also included $4.6 million of income related to the decrease of the fair value of contingent consideration relating to our infusion acquisitions, offset by a $5.5 million increase in the bad debt and contractual reserve provisions relating to the integration of our acquisitions.

PBM Services segment revenue was $16.6 million for the second quarter of 2014, compared to $16.3 million for the prior year period. The increase was related to the growth in traditional PBM volume, offset by declines in prescription discount card volume. PBM Services segment Adjusted EBITDA was $1.8 million, or 11.1% of segment revenue, for the second quarter of 2014 compared to $4.9 million, or 30.1% of segment revenue, in the prior year quarter.

On a consolidated basis, BioScrip reported $11.0 million of Adjusted EBITDA during the second quarter of 2014, or 4.5% of total revenue, compared to $10.8 million, or 6.3% of total revenue, in the same period last year. Adjusted EBITDA included $0.5 million of increased investment in reimbursement resources in the form of overtime, temporary labor and third-party professional fees.

Interest expense in the second quarter of 2014 was $9.1 million compared to $6.5 million in the prior year period.

Income tax expense for continuing operations in the second quarter of 2014 was $3.1 million compared to an income tax expense of $0.1 million in the prior year period.

The loss from continuing operations, net of taxe
'/>"/>

SOURCE BioScrip, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares
2. BioScrip Reports Third Quarter 2013 Financial Results
3. BioScrip To Host Third Quarter 2013 Earnings Call
4. BioScrip Announces 2013 Investor Day
5. BioScrip Extends The Consent Payment Deadline And Expiration Date To July 30 For Its Previously Announced Tender Offer And Consent Solicitation
6. BioScrip Reports First Quarter 2013 Financial Results
7. BioScrip To Present At "NINE" Noble Financial Capital Markets Ninth Annual Equity Conference
8. Delcath Reports 2014 Second Quarter Results
9. InterMune Reports Second Quarter 2014 Financial Results and Business Highlights
10. Neurocrine Biosciences Reports Second Quarter 2014 Results
11. Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... LA JOLLA, Calif. , Sept. 18, 2014 ... RGLS ), a biopharmaceutical company leading the ... announced today it has initiated its ATHENA natural ... syndrome, a life-threatening genetic kidney disease with no ... characterize the natural decline of renal function markers ...
(Date:9/18/2014)...   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... announced the first presentation of positive safety and ... Investigation of Collagenase Optimizing the Resolution of Dupuytrens) ... histolyticum (CCH) for the treatment of two Dupuytren,s ... the study examined expanded flexibility with timing of ...
(Date:9/18/2014)... Russia is currently experiencing a ... to deteriorate further as a result of the newly imposed ... the form of decreasing domestic demand, a weaker rouble exchange ... and international capital outflow. Exporters to ... and defaults. Some sectors are expected to be more affected ...
Breaking Medicine Technology:Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7Exporters to Russia Facing Increasing Payment Risk 2
... Risk Based on Clinical Data, ... WALTHAM, Mass., July 22 Interleukin Genetics,Inc. (Amex: ... an enhanced test report,format and information package for ... currently marketed under the brand name Gensona(R) Heart ...
... The SEAS (Simvastatin and Ezetimibe in,Aortic Stenosis) ... with the combination of simvastatin (40 mg daily) ... stenosis., Aortic stenosis (which involves partial blockage ... relatively common disease among older people in Western,populations. ...
Cached Medicine Technology:Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4
(Date:9/18/2014)... 18, 2014 After years of shooting at ... firing range berms were saturated with lead, which increased the ... in the berm and send metal fragments back at the ... splashback, and the greater the potential for injury to officers. ... to remove lead from the range environment. , ...
(Date:9/18/2014)... September 18, 2014 Sutter Health’s California ... founder of Dolby Laboratories, by naming the Ray Dolby ... of Ray Dolby provided a founding gift of $21 ... which provides services to patients and families suffering from ... people have been treated at the center since its ...
(Date:9/18/2014)... September 18, 2014 On August 23, ... Glenn with the Distinguished Service Award for his ... at the 2014 National Basketball Retired Players Association (NBRPA) ... drafted by the Chicago Bulls in 1977, Glenn would ... New York Knicks, the Atlanta Hawks, and the Milwaukee ...
(Date:9/18/2014)... MD Complete , the breakthrough ... prescription, announced today that SHAPE Magazine has named ... Peel” in its annual Beauty Awards. The issue is ... products as tested by SHAPE’s expert team. , SHAPE ... Among the thousands of beauty products launched every year, ...
(Date:9/18/2014)... September 18, 2014 Unitek ... by the Accrediting Commission of Career Schools and ... body awarded Unitek College’s community outreach efforts with ... in Community Service Award. , Unitek College ... service-learning opportunities through our Community OutReach Educational (CORE) ...
Breaking Medicine News(10 mins):Health News:Firing Range Safety is Ohio DOC Priority 2Health News:Firing Range Safety is Ohio DOC Priority 3Health News:Sutter Health’s CPMC announces Ray Dolby Brain Health Center 2Health News:Sutter Health’s CPMC announces Ray Dolby Brain Health Center 3Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 2Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 3Health News:MD Complete Wins Shape Beauty Award for Best Peel 2Health News:Unitek College Receives Award for Community Service Initiatives 2Health News:Unitek College Receives Award for Community Service Initiatives 3Health News:Unitek College Receives Award for Community Service Initiatives 4
... lymph node metastasis in patients with pancreatico-biliary carcinoma has ... and shorter survival term. , This study, performed by ... Young Chul Kim, is described in a research article ... the World Journal of Gastroenterology. , The study evaluated ...
... ALLEGAN, Mich., May 20 Perrigo Company,(Nasdaq: ... Papa, Perrigo,s,Chairman and CEO will present at the ... May 21, at 10:00 a.m. (ET) at the ... the following link, http://www.veracast.com/webcasts/citigroup/healthcare08/25105341.cfm ., Perrigo ...
... May 20 Pennsylvania, along,with 28 other states ... million,settlement, the largest ever for a multi-state consumer ... advertising related to the,drug, Vioxx. Pennsylvania will receive ... Corbett said that in 1999, Merck allegedly,launched an ...
... May 20 Depression is a serious,but treatable health ... condition will be the focus of a national campaign ... Depression, which is,supported by the Anthem Blue Cross Foundation, ... Men Get Depression National Awareness Campaign is an effort ...
... life, it may be better than standard oxygen therapy, study ... suggests that a mechanical ventilator can ease suffering and help ... , A large percentage of these patients didn,t want to ... to wear an oxygen mask. But those who were willing ...
... Against Tobacco Recognized Nationally-, WASHINGTON, May 20 ... Regional Youth Advocate of the Year,by the Campaign for ... Michelle is being honored at a gala in the ... international grant winner,three other regional winners and a group ...
Cached Medicine News:Health News:Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx 2Health News:Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 2Health News:Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 3Health News:Ventilator Relieves Lung Cancer Pain in Final Hours 2Health News:Ventilator Relieves Lung Cancer Pain in Final Hours 3Health News:Campaign for Tobacco-Free Kids Honors Michelle Mays of Rhinelander, WI As Youth Advocate of the Year 2
Inquire...
... The Trinity Biotech Captia™ Mumps IgG ... the detection and quantitative determination of IgG ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
... AUTOMATION, INC. (DAI) Mumps IgG ... intended for the detection and ... to Mumps virus in human ... be used for the determination ...
... Corporation announced the launch of the ... first bi-directional cooled-tip catheter available in the ... offers physicians the benefits of cooled ablation ... the Boston Scientific Blazer(R) catheter platform. ,Cooled ...
Medicine Products: